Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
Investing.com -- Schott Pharma (ETR:1SXP) stock fell 1% after the company announced that its Chief Financial Officer, Dr. Almuth Steinkühler, will be leaving the company at her own request.
The pharmaceutical packaging manufacturer said Dr. Steinkühler informed the board she does not seek another term in office and will depart when her current contract expires on July 31, 2025. The company has appointed Reinhard Mayer as her successor, who will take over the CFO position on August 1, 2025.
Mayer brings over 20 years of experience in various CFO roles to Schott Pharma. He most recently served as CFO at Denmark-listed Nilfisk Holding A/S and previously held the same position at Hansgrohe SE. His background also includes 15 years in global management positions, including as CFO at Swedish Medtech group Getinge.
In the same announcement, Schott Pharma confirmed that CEO Andreas Reisse’s contract has been extended through April 2026, providing continuity in the company’s top leadership despite the upcoming CFO transition.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.